YU49221B - Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova - Google Patents

Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova

Info

Publication number
YU49221B
YU49221B YU21695A YU21695A YU49221B YU 49221 B YU49221 B YU 49221B YU 21695 A YU21695 A YU 21695A YU 21695 A YU21695 A YU 21695A YU 49221 B YU49221 B YU 49221B
Authority
YU
Yugoslavia
Prior art keywords
carbon atoms
hydrogen atom
heteroatoms
erythromycin
medicaments
Prior art date
Application number
YU21695A
Other languages
English (en)
Other versions
YU21695A (sh
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Roussel-Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel-Uclaf filed Critical Roussel-Uclaf
Publication of YU21695A publication Critical patent/YU21695A/sh
Publication of YU49221B publication Critical patent/YU49221B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Jedinjenja opšte formule (I): gde: ili R1 i R2, su identični ili različiti, predstavljaju atom vodonika ili ugljovodonični radikal koji može da ima najviše 24 atoma ugljenika, zasićenih ili nezasićenih, eventualno prekinuti sa jednim ili više heteroatoma i koji po potrebi imaju jednu ili više funkcionalnih grupa, ili R1 i R2, sa atomom azota za koji su vezani, grade heterocikl koji po potrebi sadrži jedan ili više heteroatoma odabranih od azota, kiseonika i sumpora, ili R1 i R2, zajedno grade radikal gde R'1 i R'2, su isti ili različiti, predstavljaju atom vodonika ili ugljovodonični radikal sa najviše 23 atoma ugljenika, zasićenih ili nezasićenih, po potrebi prekinut sa jednim ili više heteroatoma, i koji nosi još jednu ili više funkcionalnih grupa, a Z predstavlja atom vodonika ili ostatak karboksilne kiseline koji može imati do 18 atoma ugljenika, krivudava crta na položaju 10 označava da metil može biti R ili S konfiguracije ili smeša R i S konfiguracija, kao i njegove adicione soli sa kiselinama jedinjenja formule (I). Prijava sadrži još 2 nezavisna zahteva i 18 zavisnih zahteva.
YU21695A 1994-04-08 1995-04-05 Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova YU49221B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
YU21695A YU21695A (sh) 1997-12-05
YU49221B true YU49221B (sh) 2004-11-25

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
YU21695A YU49221B (sh) 1994-04-08 1995-04-05 Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova

Country Status (49)

Country Link
US (2) US5656607A (sh)
EP (1) EP0676409B1 (sh)
JP (1) JP3000023B2 (sh)
KR (1) KR100317148B1 (sh)
CN (1) CN1059445C (sh)
AP (1) AP587A (sh)
AT (1) ATE234853T1 (sh)
AU (1) AU684939B2 (sh)
BG (1) BG61916B1 (sh)
BR (1) BR9506147A (sh)
CA (1) CA2164638C (sh)
CO (1) CO4370097A1 (sh)
CZ (1) CZ296005B6 (sh)
DE (1) DE69529934T2 (sh)
DK (1) DK0676409T3 (sh)
DZ (1) DZ1869A1 (sh)
EE (1) EE04498B1 (sh)
ES (1) ES2189820T3 (sh)
FI (1) FI111264B (sh)
FR (1) FR2718450B1 (sh)
GB (1) GB2288174A (sh)
GE (1) GEP19991836B (sh)
HR (1) HRP950217B1 (sh)
HU (1) HU215396B (sh)
IL (1) IL112954A (sh)
IS (1) IS1865B (sh)
JO (1) JO1850B1 (sh)
LV (1) LV11182B (sh)
MA (1) MA23501A1 (sh)
MD (1) MD663G2 (sh)
MY (1) MY114672A (sh)
NO (1) NO308361B1 (sh)
NZ (1) NZ284498A (sh)
OA (1) OA10200A (sh)
PE (1) PE2896A1 (sh)
PL (1) PL180837B1 (sh)
PT (1) PT676409E (sh)
RO (1) RO115634B1 (sh)
RU (1) RU2141965C1 (sh)
SA (1) SA97170757A (sh)
SI (1) SI0676409T1 (sh)
SK (1) SK284079B6 (sh)
SV (1) SV1995000018A (sh)
TN (1) TNSN95026A1 (sh)
TW (1) TW316908B (sh)
UA (1) UA44705C2 (sh)
WO (1) WO1995027720A1 (sh)
YU (1) YU49221B (sh)
ZA (1) ZA952059B (sh)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DK0922050T3 (da) * 1996-05-07 2003-11-24 Abbott Lab 3-Descladinose-2,3-anhydroerythromycin-derivater
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ATE299508T1 (de) * 1996-09-04 2005-07-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US6165986A (en) * 1997-03-10 2000-12-26 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998042720A1 (fr) * 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
WO1998056800A1 (en) * 1997-06-11 1998-12-17 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
EP1115732B1 (en) 1998-09-22 2005-06-29 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
ATE344269T1 (de) 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
NZ515027A (en) * 1999-04-16 2004-01-30 Kosan Biosciences Inc Erythromycin derivatives as antibiotics
WO2000062783A2 (en) 1999-04-16 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EA200100983A1 (ru) * 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
JP4509553B2 (ja) * 2001-07-03 2010-07-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド
CN101365785A (zh) 2002-07-01 2009-02-11 阿基昂生命科学公司,以生物技术资源部的名义经营 用于生产葡糖胺和n-乙酰氨基葡糖的方法和物质
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
CA2523134A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
EP1618120A2 (en) * 2003-04-25 2006-01-25 Chiron Corporation Novel ketolide derivatives
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
PL2550286T3 (pl) 2010-03-22 2016-07-29 Cempra Pharmaceuticals Inc Krystaliczne postaci makrolidu i ich zastosowanie
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA3130061C (en) 2013-04-04 2024-05-28 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
EP3211997A4 (en) 2014-10-08 2018-10-24 President and Fellows of Harvard College 14-membered ketolides and methods of their preparation and use
CA2980315A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
EP0676409B1 (fr) 2003-03-19
NO954942D0 (no) 1995-12-06
AP9500743A0 (en) 1995-07-31
DZ1869A1 (fr) 2002-02-17
JPH07278177A (ja) 1995-10-24
DE69529934T2 (de) 2003-09-04
AU684939B2 (en) 1998-01-08
JP3000023B2 (ja) 2000-01-17
ATE234853T1 (de) 2003-04-15
HUT73772A (en) 1996-09-30
RU2141965C1 (ru) 1999-11-27
RO115634B1 (ro) 2000-04-28
DE69529934D1 (de) 2003-04-24
FR2718450B1 (fr) 1997-01-10
AU2310795A (en) 1995-10-30
FR2718450A1 (fr) 1995-10-13
PL311871A1 (en) 1996-03-18
MD663F1 (ro) 1997-01-31
EE04498B1 (et) 2005-06-15
HU9503505D0 (en) 1996-02-28
KR100317148B1 (ko) 2002-06-22
HU215396B (hu) 1998-12-28
FI111264B (fi) 2003-06-30
JO1850B1 (en) 1995-12-27
BR9506147A (pt) 1996-04-16
SK154695A3 (en) 1996-10-02
DK0676409T3 (da) 2003-06-23
GB9506856D0 (en) 1995-05-24
CZ296005B6 (cs) 2005-12-14
GB2288174A (en) 1995-10-11
CA2164638C (fr) 2003-12-30
EE9500080A (et) 1996-12-16
LV11182B (en) 1997-04-20
BG61916B1 (bg) 1998-09-30
US5656607A (en) 1997-08-12
EP0676409A1 (fr) 1995-10-11
FI955913A (fi) 1995-12-08
YU21695A (sh) 1997-12-05
TW316908B (sh) 1997-10-01
IS1865B (is) 2003-05-02
WO1995027720A1 (fr) 1995-10-19
CA2164638A1 (fr) 1995-10-19
MD663G2 (ro) 1997-07-31
HRP950217A2 (en) 1997-08-31
NO308361B1 (no) 2000-09-04
IS4309A (is) 1995-11-17
PL180837B1 (pl) 2001-04-30
GEP19991836B (en) 1999-11-05
ES2189820T3 (es) 2003-07-16
OA10200A (fr) 1996-12-18
FI955913A0 (fi) 1995-12-08
LV11182A (lv) 1996-04-20
ZA952059B (en) 1996-03-13
UA44705C2 (uk) 2002-03-15
IL112954A0 (en) 1995-06-29
BG100150A (bg) 1996-06-28
IL112954A (en) 2000-07-16
US5760233A (en) 1998-06-02
CO4370097A1 (es) 1996-10-07
SV1995000018A (es) 1997-10-24
NZ284498A (en) 1997-07-27
CN1126997A (zh) 1996-07-17
SI0676409T1 (en) 2003-06-30
SK284079B6 (sk) 2004-09-08
PE2896A1 (es) 1996-02-12
PT676409E (pt) 2003-08-29
MA23501A1 (fr) 1995-12-31
CZ322395A3 (en) 1996-08-14
HRP950217B1 (en) 2004-06-30
CN1059445C (zh) 2000-12-13
AP587A (en) 1997-04-29
SA97170757A (ar) 2005-12-03
NO954942L (no) 1996-02-07
TNSN95026A1 (fr) 1996-02-06
MY114672A (en) 2002-12-31

Similar Documents

Publication Publication Date Title
YU49221B (sh) Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova
HUP0400694A2 (hu) A rotamáz enzim aktivitásának kis molekulájú inhibitorai, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények
DK0763049T3 (da) Nukleosid-monophosphatderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som immunundertrykkende lægemidler
SK7895A3 (en) Hydroxamic acid derivatives as metalloproteinase inhibitors their use for production of pharmaceutical agents and pharmaceutical agents with their contents
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
MY126736A (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
NZ505968A (en) Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases
ES2189079T3 (es) Efectos inmunosupresores de derivados de xantina 8-sustituidos.
KR920702348A (ko) 퀴놀론 카르복실산 유도체
ATE46696T1 (de) 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung.
DK306586D0 (da) Pyridoncarboxylsyre-derivater og fremgangsmaade til fremstilling deraf
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
IE872588L (en) Compounds
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
HRP20000733B1 (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
PH24762A (en) 1,6-naphthyridine derivatives, pharmaceutical compositions and method of use
BG105923A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
AR002259A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion, compuestos intermedios y composicion que contiene a dichos derivados.
WO2000027378A3 (en) Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
ATE54446T1 (de) Substituierte azabicycloheptane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
ES2057031T3 (es) Compuestos de nucleosido de 2'-metilidenpirimidina, su uso y metodo para su produccion.
KR910006292A (ko) 방향족 산의 n-아자비시클로 [3.3.0] 옥탄 아미드
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.